ALN-4324

DRUG2 trials

Sponsors

Alnylam Pharmaceuticals

Conditions

Obese or Overweight Healthy VolunteersType 2 Diabetes Mellitus (T2DM)

Phase 1

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

Active, not recruitingNCT06845202

Alnylam PharmaceuticalsObese or Overweight Healthy Volunteers, Type 2 Diabetes Mellitus (T2DM)

Start: 2025-03-03End: 2027-08-31Updated: 2026-09-16

Phase 2

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

RecruitingNCT07465224

Alnylam PharmaceuticalsType 2 Diabetes Mellitus (T2DM)

Start: 2026-01-15End: 2027-05-28Target: 24Updated: 2026-09-16